COMMUNIQUÉS West-GlobeNewswire

Forty Seven Inc. Expands Collaboration with Genentech to Include Third Clinical Trial in Non-Hodgkin’s Lymphoma
26/04/2019
-- Plan to evaluate Forty Seven’s CD47 antibody in combination with Genentech’s CD20 and PD-L1 antibodies with the aim of engaging both T-cell and macrophage components of the immune system against Diffuse Large B-cell [...]
Outlook Therapeutics Announces Addition of Jennifer M. Kissner, Ph.D. as Senior Vice President, Clinical Development
26/04/2019
CRANBURY, N.J., April 26, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”), a clinical-stage biopharmaceutical company focused on developing its lead clinical program, ONS-5010, a [...]
Tauriga Sciences Inc. Creates Alternative Version of its Graphic Design for Mint Flavor Tauri-Gum Blister Pack
26/04/2019
New York, NY, April 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Establishment Labs to Present at UBS Global Healthcare Conference
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Mereo Biopharma to Announce Preliminary Results for the Full Year 2018 and Host Conference Call on April 29, 2019
26/04/2019
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") LONDON, April 26, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH) (NASDAQ: MREO), a clinical stage, UK-based, biopharmaceutical company [...]
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies and Reports Preliminary First Quarter 2019 Financial Results
26/04/2019
Proposed acquisition establishes a key franchise for Repligen in the rapidly growing Process Analytics segment of bioprocessing Adds a market leader in protein concentration measurement with proprietary and [...]
Editorial in Pharmagenomics explains how DRP® can guide the treatment for breast cancer
26/04/2019
Investor News Hørsholm, Denmark and Cambridge, MA, US, April 26, 2019 – Oncology Venture A/S announced today that an editorial published in Pharmagenomics explains how the DRP ® can guide the treatment for breast cancer [...]
CURE Pharmaceutical Named “Innovative Business of the Year” By Oxnard Chamber of Commerce
26/04/2019
OXNARD, Calif., April 26, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, has been named 2019’s Innovative Business of the Year by Oxnard Chamber [...]
Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst®-Lung liquid biopsy test
26/04/2019
Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst ® -Lung liquid biopsy test InVisionFirst ® -Lung demonstrated excellent concordance with tissue profiling and detected [...]
CARLA GOFFSTEIN STEPS INTO CFO ROLE AT TWINLAB
25/04/2019
Boca Raton, Fla., April 25, 2019 (GLOBE NEWSWIRE) -- Twinlab Consolidated Holdings, Inc. (OTCPK: TLCC ) (“TCC” or “Twinlab”) has promoted senior vice president of finance, Carla Goffstein to chief financial officer (CFO [...]
BioDelivery Sciences to Report First Quarter 2019 Financial Results
25/04/2019
RALEIGH, N.C., April 25, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients living with chronic [...]
The Cooper Companies Announces Release Date for Second Quarter 2019
25/04/2019
PLEASANTON, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced it will release second quarter 2019 financial results on Thursday, May 30, 2019, at 4:15 PM ET. Following the [...]
Inspire Medical Systems, Inc. Announces an Additional 10.4 Million Covered Lives with New Coverage Policies
25/04/2019
MINNEAPOLIS, April 25, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
MRI Interventions, Inc. to Announce First Quarter 2019 Results on April 30
25/04/2019
IRVINE, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed to deliver navigation, ablation, deep brain stimulation, biopsy and gene [...]
Oxford Immunotec Schedules First Quarter 2019 Earnings Release and Conference Call for May 9, 2019
25/04/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to [...]
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 2, 2019
25/04/2019
GAITHERSBURG, Md., April 25, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2019 financial and operating results following the close of U.S. financial markets on [...]
Dynavax Technologies to Report First Quarter 2019 Financial Results and Host Conference Call on May 8
25/04/2019
BERKELEY, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology [...]
BioTelemetry, Inc. Reports First Quarter 2019 Financial Results
25/04/2019
Achieves Record Quarterly Revenue Raises Full Year 2019 Guidance MALVERN, Pa., April 25, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery [...]
Natus Medical Announces First Quarter 2019 Financial Results
25/04/2019
First quarter revenue of $114.8 million First quarter GAAP loss per share of $0.74; non-GAAP earnings per share of $0.09 PLEASANTON, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) ( [...]

Pages